| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.5 | 0.009 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.51 | 0.01 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.66 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.48 | 0.01 |